Dr. Reuben is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 Post Rd Ste 204
Fairfield, CT 06824Phone+1 203-255-4545
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 2001
Case Western Reserve University School of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2000 - Present
CT State Medical License 2001 - 2025
SC State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24
Publications & Presentations
PubMed
- 2 citationsImpact of COVID-19 in patients on active melanoma therapy and with history of melanoma.Douglas B Johnson, Michael B Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman
BMC Cancer. 2023-03-23 - 3 citationsDemographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P Shah
Cancers. 2022-09-05 - 9 citationsClinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn
Journal for Immunotherapy of Cancer. 2022-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
